Streamline your biomanufacturing process with the latest research and up-to-date case studies from Bayer Pharma, GSK, Sandoz, Novo Nordisk, IBET and many more
Optimise your cell culture technology by meeting key biotech and solution providers such as GE, Merck Millipore, Thermo Fisher and more
Network with top bioprocess scientists from leading pharmaceutical, biotechnology and research
Through a variety of interactive formats; position yourselves at the cutting edge of the cell line, media, process development and single-use markets.
Up to 500 process scientists and decision makers from top pharma and biotech attend in order source the latest technology and to hear the latest innovations.
'Very well organised conference with excellent networking facilities'
Nico Verlinden, Perkin Elmer
‘Good exhibition area, good traffic’
Rudolf Schmitt, GE Healthcare Europe
‘Interesting talks and high level discussions with good networking’
Markus Sack, RWTH Aachen University
At the 2014 World Drug Safety Congress Americas, Anne Wolka, Eli Lilly and Company, gave a presentation on “New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment”. Download and learn: The rebirth of the PSUR Objective of the PBRER Critical Analysis of Benefits Critical Analysis of Risks Integrated Benefit-Risk Analysis Impact of the PBRER So What Is a […]
The post New Benefit-Risk PSUR: Impact on Benefit-Risk Assessment appeared first on Total Biopharma.
The Pharmaceutical and Biotechnology continue to dominate the world’s R&D expenditure, with more companies in the top 10 than any other sector. This year, whilst Novartis has knocked Roche from their top spot, individual R&D spends by pharma and biotechs fail to compete with the likes of Volkswagen and Samsung who’s spends were around $11 […]
Earlier this year at BioPharma Asia Convention, when we spoke to some speakers about their thoughts on the key growth strategy that Asian biotech companies should adopt, there seemed to be a unanimous agreement that looking beyond Asia is the way to go. “Biotech companies in Asia have to think globally, and link globally. “ […]
Innovation and strategy for pharmaceutical, biotech and R&D